Colorectal Cancer Dataset in Xijing Hospital From 2011

Recruiting

• Conditions: Nutrition Related Cancer; Prognostic Cancer Model; Chemotherapy

• Registration Number: NCT06308354
• Lead Sponsor: Xijing Hospital

Brief Summary

To compare the differences of clinical pathological, treatment and prognosis in the guided subgroups in colorectal cancer, the investigator enrolled all the colorectal cancer patients who underwent surgery and were hospitalized in the Xijing hospital.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-01-01
• Status Verified: 2024-01
• Study First Submitted: 2024-02-18
• Study First Submitted QC: 2024-03-11
• Last Update Submitted: 2024-03-11
• Study First Posted: 2024-03-13
• Last Update Posted: 2024-03-13
• Primary Completion: 2048-01-01
• Study Completion: 2048-01-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 40000

Inclusion Criteria

• 1. Pathologically confirmed colorectal adenocarcinoma, including hereditary colorectal cancer syndrome, such as Lynch syndrome and familial adenocarcinoma tumor polyposis, Peutz Jeghers syndrome, juvenile polyposis syndrome, and serrated polyposis syndrome;
• 2. Visit our center with complete medical records and pathological information;
• 3. Colorectal cancer patients diagnosed between 2013 and 2023.

Exclusion Criteria

• 1. The patient has other colorectal malignancies other than adenocarcinoma;
• 2. Malignant tumors adjacent to organs invading the colon and rectum;
• 3. Malignant tumors from distant organs metastasize to the colon and rectum;
• 4. Benign colorectal lesions; 5. Patients with recurrent colorectal cancer.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
overall survival	from date of diagnosis until the date of death from any cause, assessed up to 120 months	to dead or lost to follow
DFS	from date of diagnosis until the first documented progression or recurrence, assessed up to 120 months	disease-free survival

Trial Locations

Locations (1)

Fourth Military Medical University; 🇨🇳 Xi'an, Shaanxi, China